Galecto Strengthens Board of Directors with Appointment of Dr. Amy Wechsler
| EPRSQDelisted Stock | USD 0.0001 0.00 0.00% |
Slightly above 56% of EPIRUS Biopharmaceutica's investor base is looking to short. The analysis of overall sentiment of trading EPIRUS Biopharmaceuticals pink sheet suggests that many investors are alarmed at this time. EPIRUS Biopharmaceutica's investing sentiment overview a quick insight into current market opportunities from investing in EPIRUS Biopharmaceuticals. Many technical investors use EPIRUS Biopharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
EPIRUS |
BOSTON, Oct. 15, 2024 -- Galecto, Inc. , a clinical-stage biotechnology company focused on the development of novel...
Read at globenewswire.com
 |
EPIRUS Biopharmaceutica Fundamental Analysis
We analyze EPIRUS Biopharmaceutica's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EPIRUS Biopharmaceutica using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of EPIRUS Biopharmaceutica based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Earning
Price To Earning Comparative Analysis
EPIRUS Biopharmaceutica is currently under evaluation in price to earning category among its peers. Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
EPIRUS Biopharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with EPIRUS Biopharmaceutica pink sheet to make a market-neutral strategy. Peer analysis of EPIRUS Biopharmaceutica could also be used in its relative valuation, which is a method of valuing EPIRUS Biopharmaceutica by comparing valuation metrics with similar companies.
Peers
EPIRUS Biopharmaceutica Related Equities
| OPT | Opthea | 13.08 | ||||
| GLTO | Galecto | 12.28 | ||||
| FBRX | Forte Biosciences | 8.78 | ||||
| GNTA | Genenta Science | 4.45 | ||||
| MLYS | Mineralys Therapeutics, | 4.30 | ||||
| PHVS | Pharvaris | 2.20 | ||||
| CNTA | Centessa Pharmaceuticals | 1.34 | ||||
| PEPG | PepGen | 1.01 | ||||
| MOLN | Molecular Partners | 0.57 | ||||
| HLVX | Hillevax | 0.53 | ||||
| ERAS | Erasca | 0.52 | ||||
| NAMSW | NewAmsterdam Pharma | 0.56 | ||||
| ANTX | AN2 Therapeutics | 0.79 | ||||
| EWTX | Edgewise Therapeutics | 0.91 | ||||
| STRO | Sutro Biopharma | 1.01 |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Consideration for investing in EPIRUS Pink Sheet
If you are still planning to invest in EPIRUS Biopharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the EPIRUS Biopharmaceutica's history and understand the potential risks before investing.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| CEOs Directory Screen CEOs from public companies around the world |